Morimatsu International Holdings Company Limited

Morimatsu International Holdings Company Limited

5.79
HKD
-0.26
(-4.30%)
11.48BMarket Cap
Apr 01Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.57
2.47
2.83
2.98
4.79
6.17
6.33
5.83
5.7
- -
Basic EPS, GAAP
0.01
0.12
0.15
0.29
0.43
0.64
0.73
0.62
0.49
- -
Free Cash Flow per Basic Share
0.34
0.2
0.07
0.03
0.82
0.01
0.09
0.61
0.06
- -
Dividend per Share
0.01
0.15
- -
- -
0.03
- -
- -
0.09
0.14
- -
Book Value per Share
1.41
1.07
0.71
1
1.94
2.62
3.68
4.14
4.5
4.5
Tangible Book Value per Share
1.22
0.89
0.58
0.86
1.8
2.43
3.51
3.95
4.19
4.19
Basic Weighted Avg Shares
1,000
1,000
1,000
1,000
895
1,051
1,163
1,191
1,220
1,223
Sales/Revenue/Turnover
1,570
2,468
2,826
2,979
4,286
6,486
7,360
6,948
6,955
- -
Operating Margin (%)
1.42
5.73
5.94
12.7
11.1
12.11
12.88
11.94
9.48
- -
Depreciation Expense
88
88
83
77
93
114
145
195
238
- -
Net Income, GAAP
7
116
149
289
382
669
845
737
600
- -
Effective Tax Rate (%)
49.66
17.67
15.11
15.24
14.99
12.45
14.4
19.9
18.51
- -
Profit Margin (%)
0.45
4.71
5.28
9.72
8.91
10.32
11.48
10.61
8.62
- -
Working Capital
136
218
-212
22
620
955
2,123
2,701
3,169
3,169
LT Debt
4
380
16
2
2
207
194
181
44
44
Total Equity
1,438
1,110
707
998
2,008
2,823
4,391
5,276
5,858
5,858
Return on Invested Capital (%)
- -
9.06
10.31
22.64
20.54
23.29
20.76
14.01
9.93
- -
Return on Capital (%)
- -
6.72
11.16
22.86
20.97
24.2
21.28
14.55
10.61
- -
Return on Common Equity (%)
- -
9.39
16.79
33.94
25.4
27.75
23.47
15.63
11.26
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
115
172
373
LT Borrowings
126
81
- -
LT Finance Leases
54
52
44
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,220
1,245
1,245
Market Capitalization
5,019
6,865
10,318

Working Capital

CNY

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
6,079
6,714
6,982
Cash, Cash Equivalents & STI
2,992
3,174
3,284
Accounts Receivable, Net
1,036
948
971
Inventories
797
1,023
730
Total Current Liabilities
3,378
3,948
3,812
Payables & Accruals
- -
- -
- -
ST Debt
115
172
373
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
45.69%
11.04%
Free Cash Flow
- -
742.35%
-89.15%
Net Income, GAAP
- -
20.41%
-18.67%
Sales/Revenue/Turnover
- -
20.64%
0.09%
Total Cash Common Dividend
- -
- -
53.84%

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
7,360
2024
- -
- -
6,948
2025
- -
- -
6,955

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.73
2024
- -
- -
0.62
2025
- -
- -
0.49

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.09
2025
- -
- -
0.14

Company Description

CEO
Koei Nishimatsu
Full Time Employees
4,800
Sector
Producer manufacturing
Industry
Industrial machinery
Address
No. 29, Jinwen Road Shanghai SH China
IPO Date
Jun 28, 2021
Business
Morimatsu International Holdings Company Limited manufactures pressure equipment and provides integrated solutions for core process equipment, process systems, and engineering projects serving industries including oil and gas refining, pharmaceuticals, biopharmaceuticals, new chemical materials, power battery raw materials, electronic chemicals, and fast-moving consumer goods; its core products encompass traditional pressure vessels such as heat exchangers, tanks, reactors, and towers, alongside modular equipment including process modules, skids, modular factories, bioreactor systems, fermenters, parallel bioreactors, biodownstream systems, ultrafiltration systems, inline buffer dilution systems, preparation systems, CIPS workstations, sanitary tanks, wet granulators, multifunctional fluidized beds, filter washing dryers, crystallizing tanks, disposable bag storages, multifunctional utility panels, and data centers; the company also delivers value-added services comprising design, validation, installation, operation, maintenance, biotechnology consulting, structural and special equipment design, engineering cost consultancy, and technical support. Founded in 1990 and headquartered at No. 29 Jinwen Road, Zhuqiao Town, Pudong New District, Shanghai, China, Morimatsu operates globally with approximately 4,500 employees across domestic and international markets, including subsidiaries focused on biopharmaceutical solutions and high-purity chemical equipment. In recent developments, the company completed the acquisition of Bioengineering AG on September 10, 2025, enhancing its biopharmaceutical capabilities with advanced modular plant solutions and process equipment expertise; it earned Samsung E&A's "Supplier of the Year" award for the third time in September 2025, underscoring a decade-long partnership; and established a new wholly-owned subsidiary in March 2024 to support ongoing expansions.